All articles by Srijanee Chakraborthy

  1. Acucela begins enrolment in Phase IIa study of emixustat hydrochloride to treat Stargardt disease

    US-based clinical-stage ophthalmology company Acucela, a subsidiary of Kubota Pharmaceutical, has begun enrolment for its Phase IIa study of emixustat…
    Read More…

    26 Jan
  2. Flex Pharma to conduct Phase II clinical programmes of FLX-787 to treat neurological diseases

    US-based biotechnology company Flex Pharma is planning to conduct Phase II clinical programmes to evaluate FLX-787 for treatment of severe…
    Read More…

    25 Jan
  3. Daiichi Sankyo begins Phase I/II trial of U3-1402 to treat breast cancer in Japan

    Japanese-based pharmaceutical company Daiichi Sankyo has begun its Phase I/II trial of U3-1402 to treat patients with HER3-positive metastatic or…
    Read More…

    19 Jan
  4. UCB and Dermira report positive Phase III trial results of Cimzia to treat chronic plaque psoriasis

    UCB and Dermira have reported positive results from its Phase III CIMPACT trial of Cimzia (certolizumab pegol) to treat adult…
    Read More…

    19 Jan
  5. Protagonist Therapeutics initiates Phase IIb trial of PTG-100 to treat ulcerative colitis

    US-based clinical-stage biopharmaceutical company Protagonist Therapeutics has initiated its Phase IIb clinical trial of PTG-100 to treat ulcerative colitis. PTG-100…
    Read More…

    18 Jan
  6. Interface Clinical Research suggests new model for primary care clinical trials in UK

    UK-based clinical trials company Interface Clinical Research has suggested a new model to conduct primary care clinical trials following their…
    Read More…

    18 Jan
  7. SWOG to conduct immunotherapy clinical trial to treat rare cancers

    SWOG, a part of National Cancer Institute’s National Clinical Trials Network and the NCI Community Oncology Research Programme, has launched…
    Read More…

    18 Jan
  8. Allergan and Gedeon Richter report positive results from Venus II trial of ulipristal acetate

    Allergan and Gedeon Richter have reported positive results from Venus II, the second of two pivotal phase III clinical trials…
    Read More…

    17 Jan
  9. Jazz Pharmaceuticals begins enrolment in Phase III trial of defitelio to treat VOD

    Ireland-based Jazz Pharmaceuticals has begun patient enrolment in a Phase III clinical trial of defitelio (defibrotide sodium) against best supportive…
    Read More…

    17 Jan
  10. New clinical trial to test drug combination to treat osteogenesis imperfecta

    The University of Edinburgh will conduct a six-year trial of teriparatide and zoledronic acid combination to treat a condition called…
    Read More…

    17 Jan